Britta
Leverentz and William Conway:
Focusing on Phage-Enhanced Food Safety
USDA Agricultural Research Service plant pathologists Britta Leverentz
and William Conway, working out of the ARS Produce Quality and Safety
Laboratory in
Beltsville,
Maryland, recently announced the successful conclusion of the first phase
of a study which sought to control foodborne pathogens on fresh-cut fruits
and vegetables through the use of bacteriophages—viruses that infect and
kill bacteria. This first-of-its-kind study was part of a cooperative
agreement with Intralytix, Inc.—a
Baltimore, Maryland-based Corporation which provided known phages for
Salmonella strains as a model. FoodTechSource.com recently spoke with
Leverentz and Conway to better understand the impact of their work.
FoodTechSource.com: Can you provide an overview of your
research?
Britta Leverentz, Ph.D.: We investigate food safety issues—in
this case the elimination, using biocontrols, of foodborne pathogens
present on the surface of fresh-cut fruits and vegetables. We have
investigated a number of different factors: the role played by pH, acidity
and storage temperature, and the potential use of bacteriophages, which
can target specific bacteria.
FTS: What are phages and how do they fit into your study?
Leverentz: Phages are naturally occurring viruses that attack
and kill bacteria. They have a protein head and a tail. Inside the head is
their DNA—genetic information packaged in a protein coat. The phages
reproduce by attaching themselves to the surface of the bacteria, then
inserting their DNA. They then begin to replicate until their numbers are
sufficient to rupture the bacteria, killing it. Then they move on to the
next host. Phages are the focus of our study because they are very
specific and can be used to target specific bacteria. For example, if you
have a phage that is active against salmonella it may not be active
against other bacteria.
William S. Conway, Ph.D.: That is important because many of the
organisms present on fresh fruit are beneficial organisms. And if, for
example, you use a chemical like chlorine to kill the pathogen, it kills
everything—harmful as well as helpful organisms. But the phage, being more
specific, kills the harmful bacteria while allowing the beneficial
organisms to remain on the surface.
FTS: I’m very curious about this specificity aspect. How
specific are these viruses? Because you can have both good and bad E. coli
in your digestive track as well; can you capture a phage that can
specifically target the harmful E. coli so if it got into your gut it
would leave the beneficial E. coli alone?
Leverentz: Certainly. If it’s a phage that targets E. coli, it
doesn’t necessarily target all strains of E. coli. Theoretically you
should be able to find and isolate a phage that targets only one
particular strain of E. coli.
FTS: Did you attempt to do that in your study? Or were you just
studying phages as a broad, overall tool?
Leverentz: We used phages as a tool here at the USDA. We were
investigating how effective phages can be at eliminating foodborne
pathogens and how the technology might be applied. The phage itself is
supplied by a Baltimore company called
Intralytix. We have a Cooperative Research and Development
Agreement with that company and they isolate the phages.
FTS: So, Intralytix
will be taking it to the next step when you’ve finished with your work?
Leverentz: We will work together on a pilot project to address
issues of applying the technology on a larger scale; we do expect that
Intralytix will commercialize the technology, as stipulated by the current
CRADA between the USDA and the company.
FTS: How did you proceed with your project? What was the
protocol?
Leverentz: We tried to simulate in-store conditions and
procedures. We cut up fruits and vegetables and contaminated the samples
with salmonella bacteria. Then we applied the phage, using a variety of
different application methods and mixtures, and stored the produce under a
variety of conditions to see if that had an effect. In recording the
results we isolated back from the tissue to determine the number of
bacteria that remained and also to determine if the phage was still
surviving.
FTS: When you say “a variety of mixtures” what do you mean?
Leverentz: What I mean is that we tried a variety of phage
“cocktails.” The phage is specific, but there may be several different
strains of the bacteria present. Also, the bacteria can mutate. So, we use
a phage cocktail that will be effective against a broad selection of the
bacteria we want to target.
FTS: How were these phage cocktails applied to the fruit?
Sprays? Washes? Dipping?
Leverentz: We had small specimens and just used a pipette to
apply a specific amount of liquid to the produce.
Conway: This work really is in its infancy right now. No one has
done this before on fruits and vegetables. This is the first step. We need
to see first if it is going to be effective—which it seems to be—and then
we can develop an effective method for applying it. Spraying would be the
main way to apply it because we’d need to put a spray somewhere along the
line where they actually process these items. But right now we’re just in
the process of seeing how it works, and how we can tweek it so it works
even better. The next step would be to run some type of pilot test so it
might be better adapted to the needs of industry.
FTS: Have phages been tested on any other food products?
Conway: Intralytix is presently doing some research on eggs and
poultry, and I heard it was getting close to the commercial stage. You
see, up to this point most foodborne pathogen outbreaks have involved
meats and poultry. But with fresh-cut produce gaining popularity the
potential for outbreaks in this area is increasing. That’s why we
undertook our study.
FTS: Did you only study the effects of phages on fresh-cut
produce? Because produce can get bruised during distribution as well and I
would think those knicks and cuts would allow pathogens to enter the
produce.
Conway: Certainly the main application for this technology would
be fresh-cut fruits and vegetables, because it’s very difficult for these
foodborne pathogens to multiply on the outer skins and peels of whole
fruits and vegetables. On the other hand, yes, you do get damage during
handling, and phage use could prove beneficial in the distribution phase.
But when produce is cut, that’s when pathogens are provided with a fresh
substrate where they can really multiply and take hold.
FTS: How effective are phages in controlling foodborne
pathogens?
Leverentz: We got a 3- to 5-log reduction in organisms,
depending upon the treatment. On apples we still have a problem with the
acidity because a phage does not function well in an acidic environment.
But on honeydew melons, for example, the pH is just right and the numbers
can drop up to 5-log. That’s the upper end.
FTS: Are those the numbers you are looking to get?
Leverentz: Yes, the industry standard is a 5-log reduction.
Using chlorine, for example, you get maybe 1.8- to 2.5-log reduction. So
it’s more effective than chlorine.
FTS: Does temperature have any effect?
Leverentz: Phages are more effective at low temperature. They
are effective at higher temperatures as well, but the growth of the
bacteria is also higher at those temperatures.
Conway: Most fresh-cut fruits and vegetables are intended to be
stored at about 5°C, but often they are stored at 10°C, which is an
abusive temperature. So, most of our work was done at between 5 and 10°
because that is what is actually happening in industry.
FTS: Did you focus solely on salmonella or did you attempt
cocktails that targeted multiple pathogens such as both salmonella and E.
coli?
Leverentz: Right now we are not mixing the different phages. We
could, if we wished, use a cocktail that would target, for example,
Salmonella and E. coli, as well as listeria—and that is something we will
probably try down the line. For this study, however, we targeted only
Salmonella, and we used a cocktail that included maybe four to six
different Salmonella phages. Our primary reason for this was to study the
potential for the bacteria to develop a resistance. With antibiotics, for
example, bacteria try to develop resistance—and often succeed. But by
using a cocktail, if the bacteria try to develop resistance against one
phage, there are four or five other phages present which they will not
have resistance against. It is much, much harder for the bacteria to
overcome that.
FTS: Have you any suspicion that if you mix the phages for
Salmonella and E. coli, for example, there would be a drop in
effectiveness? Or are you assuming that down the road when you try that
the response will be equally effective?
Leverentz: I don’t see a reason why such a cocktail would not be
effective, because the bacteriophages do not compete. They are very
specific for their target organism. But that’s really speculation at this
point.
FTS: In the area of phage collection, is it easy to get new
phages or phages that respond to new bacterial strains that might develop?
Do researchers just find a phage that works for the new strain and then
just multiply it commercially?
Leverentz: Yes. It’s quite easy to isolate lots of different
phages. Intralytix actually
gets most of its phages from the water in the Baltimore inner harbor and
Chesapeake Bay. There can reportedly be up to 8 million phages in one
milliliter of fresh water. It’s just laborious to find the right one.
Conway: Phages are nothing if not plentiful. I have heard it
reported that if you weighed all the elephants in the world and all the
phages, the phages would outweigh the elephants.
FTS: Is there any reason to use genetic manipulation on these
phages?
Leverentz: I don’t believe there is reason to do any genetic
modification.
FTS: In terms of bringing this technology to market, what
problems or dangers do you foresee?
Leverentz: I don’t foresee dangers. It is a very safe technique
to use. In creating the phage cocktail, the different strains that are
used would probably need to be rotated or renewed after a while to make
sure the bacteria are not gaining resistance. That would be an ongoing
process. There are also issues with large, industrial-scale production
that would need to be worked out—particularly in regard to the method of
application and storage temperature.
Conway: It also would be something of a long, drawn-out affair
because anytime you have anything to do with food you need FDA approval
and that takes time. But I don’t see a problem as far as danger to humans.
In fact, phages were used to treat human maladies back in the 1930s before
antibiotics became popular. But now with resistance to antibiotics
increasing somewhat, phage research has found renewed interest.
FTS: How long do you believe it might take?
Conway: To get clearance I honestly couldn’t say whether it
would take months or years.
FTS: Would this fall under the Generally Regarded as Safe (GRAS)
classification? Or since phages do have an effect on bacteria in the body
might you need full-blown FDA approval?
Leverentz: That’s something the agencies responsible would need
to answer. I certainly would consider it as GRAS, but that is not up to me
to say.